TC
MRNA icon

Titleist Capital’s Moderna MRNA Stock Holding History

Titleist Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$13.9M Sell
77,130
-1,649
-2% -$270K 3.25% 4
2022
Q3 		$9.32M Buy
78,779
+2,676
+4% +$406K 2.13% 8
2022
Q2 		$10.9M Buy
76,103
+5,002
+7% +$715K 2.64% 5
2022
Q1 		$12.2M Buy
71,101
+5,686
+9% +$957K 2.43% 9
2021
Q4 		$16.6M Buy
+65,415
New +$19.1M 3.19% 5

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Titleist Capital's MRNA Position: Q4 2022 in Review

Titleist Capital reduced its Moderna (MRNA) stake by 2.1% in Q4 2022, selling an estimated $270K and leaving 77,130 shares worth $13.9M. The position accounts for 3.25% of the portfolio, ranked #4.

Titleist Capital first reported a position in MRNA in Q4 2021 and has held it in 5 quarters since. The position peaked at $16.6M in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Titleist Capital held 77,130 shares of Moderna worth $13.9M as of Q4 2022.
  • Titleist Capital sold 1,649 Moderna shares in Q4 2022, an estimated $270K.
  • Moderna made up 3.25% of Titleist Capital's portfolio in Q4 2022, its #4 holding.
  • Titleist Capital first reported a position in Moderna in Q4 2021 and has held it in 5 quarters since.
  • Titleist Capital's Moderna position peaked at $16.6M in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.